Educational Attainment and Drug Firm Innovation
Journal of Applied Business and Economics · 29.07.2026 · 28 (4)
DOI: 10.33423/wxxs2c39 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Business and Economics, online erschienen am 29.07.2026. Verfasst von Xiaoming Liu und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Few researchers have distinguished the marginal effects of educational attainment within the tertiary level on firm-level innovation. We examine the impact of academic degrees on firms’ innovation activities in the talent-demanding drug industry in China. We find that the educational attainment factors, along with R&D spending, tend to dominate other types of firm capital in innovation output. More importantly, our findings on innovation efficiency could reconcile some conflicting views for large and small firms in the literature. Further, small-molecule drugs have received far more patents than biologics, but the latter have had a similar number of drug pipelines.
Zitieren
APA
Liu, X., Zhou, S., & Zhang, Z. (2026). Educational Attainment and Drug Firm Innovation. Journal of Applied Business and Economics, 28(4). https://doi.org/10.33423/wxxs2c39
Vancouver
Liu X, Zhou S, Zhang Z. Educational Attainment and Drug Firm Innovation. Journal of Applied Business and Economics. 2026;28(4). doi:10.33423/wxxs2c39
BibTeX
@article{Liu2026,
author = {Liu, Xiaoming and Zhou, Shanshan and Zhang, Zhaohui},
title = {Educational Attainment and Drug Firm Innovation},
journal = {Journal of Applied Business and Economics},
year = {2026},
volume = {28},
number = {4},
doi = {10.33423/wxxs2c39}
}
EUVIMED